PURA Is Cannabis Acquisition Candidate According To Analyst Report Indicating $0.35 PPS Potential
28 Febbraio 2019 - 7:00PM
InvestorsHub NewsWire
New York, NY
-- February 28, 2019 -- InvestorsHub NewsWire -- via
NextBigTicker.com -- Goldman Small Cap Research issued a research update on
Puration, Inc. (USOTC:
PURA) recommending a 'speculative-buy' rating with a
target price-per-share of $0.25, with noted potential upside
to the $0.35 mark.
PURA has released major news this week with the debut of its all new EVERx CBD Sports Water at the
Arnold Sports Festival starting today in Columbus, Ohio.
In reaction to the announcement the share price has more than
doubled hitting a high of $0.15 on over 100 million shares of
trading volume over the course of two days. The PPS has
retraced as of this writing to $0.11 on less than half of the
trading volume that took the price up. The PPS is showing
healthy consolidation and building a base to head toward the
analyst indicated upside potential of $0.35
“There is
substantial interest in hemp-derived CBD-infused products, as
evidenced by the flurry of M&A, investment activity and talk by
major beverage companies such as Constellation, Brands (STZ),
Diageo, Tilray (TLRY),
Coca-Cola (COKE),
Starbucks, etc. Once critical mass of sales is achieved,
given its broad popularity, PURA could emerge as an M&A
target,” concluded Goldman.
Find Goldman’s
full update report below:
Published by NextBigTicker.com
Grafico Azioni Constellation Brands (NYSE:STZ)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Constellation Brands (NYSE:STZ)
Storico
Da Dic 2023 a Dic 2024